Leprosy downgrading reaction associated with griseofulvin

Area of Science:

• Dermatology
• Infectious Diseases
• Immunology

Background:

• Leprosy is a chronic infectious disease caused by Mycobacterium leprae.
• Leprosy is classified based on clinical and immunological parameters, including tuberculoid and lepromatous forms.
• Cell-mediated immunity plays a crucial role in controlling leprosy progression.

Observation:

• A 29-year-old male patient with subpolar tuberculoid leprosy was treated with griseofulvin.
• The patient exhibited a dramatic clinical alteration from tuberculoid to lepromatous leprosy during griseofulvin therapy.
• The patient's cell-mediated immunity appeared normal throughout the observation period.

Findings:

• This case represents the first reported instance of a leprosy downgrading reaction associated with griseofulvin.
• The observed reaction suggests griseofulvin may negatively impact the immune response in leprosy.
• Griseofulvin's potential inhibition of polymorphonuclear leukocyte chemotaxis is hypothesized as the underlying mechanism.

Implications:

• This finding highlights a potential adverse effect of griseofulvin in leprosy patients.
• Further research is warranted to elucidate the immunomodulatory effects of griseofulvin in infectious diseases.
• Clinicians should be aware of this potential reaction when prescribing griseofulvin to leprosy patients.